Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long TEM Daily ETF

23.09
-2.4700-9.66%
Pre-market: 22.41-0.6800-2.94%04:48 EDT
Volume:152.51K
Turnover:3.66M
Market Cap:35.06M
PE:- -
High:26.01
Open:24.70
Low:22.87
Close:25.56
52wk High:152.22
52wk Low:11.52
Shares:1.52M
Float Shares:1.52M
Volume Ratio:1.01
T/O Rate:10.04%
Dividend:3.85
Dividend Rate:16.67%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

JPMorgan: The AI Trade Won't Lead the Market in the Second Half

Analyst Calls
·
Aug 04

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Aug 04

Tempus AI price target lowered to $56 from $64 at H.C. Wainwright

TIPRANKS
·
Aug 04

Tempus AI is Maintained at Hold by Stifel

Dow Jones
·
Aug 03

Tempus AI–Personalis Deal: Integration Risks, Rising Costs, and Regulatory Scrutiny Could Undermine Synergy Gains

TIPRANKS
·
Aug 01

Tempus AI Price Target Maintained with a $75.00/Share by Needham

Dow Jones
·
Jul 31

Tempus AI Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

OpenAI Suddenly Unleashes! GPT 5.6 Series Prices Slash Up To 80%, AI Begins Self-Optimizing Code For Quantum Leap

AI Industry Frontlines
·
Jul 31

Tempus AI CEO and Chairman Eric Lefkofsky Disposes of USD 10.75 Million in Common Shares

Reuters
·
Jul 31

Tempus AI Inc Shares Fall 2% After the Bell Following Results, Outlook

THOMSON REUTERS
·
Jul 31

GUIDANCE: (TEM) Tempus AI Expects Full Year 2026 Revenue Range $1.595B - $1.605B, vs. FactSet Est of $1.59B

MT Newswires Live
·
Jul 31

Tempus AI Q2 FY26 Swings to GAAP Profit of $5.64 Million; Revenue Rises 22% to $382.5 Million

Reuters
·
Jul 31

Tempus AI Q2 Revenue Slightly Beats Estimates

Reuters
·
Jul 31

Tempus AI Q2 Adj. EPS $(0.04) Beats $(0.14) Estimate, Sales $382.486M Beat $379.743M Estimate

Benzinga Earnings
·
Jul 31

Tempus AI Inc Q2 Income from Operations USD -75.913 Million

THOMSON REUTERS
·
Jul 31

Tempus AI Inc Q2 Adjusted EPS USD -0.04 VS. Ibes Estimate USD -0.14

THOMSON REUTERS
·
Jul 31

tempus AI Inc Class A options imply 6.9% move in share price post-earnings

TIPRANKS
·
Jul 31

Median Technologies Partners with Canon’s Olea Medical to Commercialize Eyonis LCS Lung Cancer Screening Software

Reuters
·
Jul 30

Sløk Flags Systemic Cross-Asset Risks; AI Turmoil Is Just The Starting Point

Analyst Calls
·
Jul 30

More Cracks Appear Inside The AI Bond Market!

AI Industry Frontlines
·
Jul 28